SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Vivos Inc – ‘10-Q’ for 9/30/17 – ‘EX-101.CAL’

On:  Monday, 11/13/17, at 6:22am ET   ·   For:  9/30/17   ·   Accession #:  1493152-17-12763   ·   File #:  0-53497

Previous ‘10-Q’:  ‘10-Q’ on 8/11/17 for 6/30/17   ·   Next:  ‘10-Q’ on 5/22/18 for 3/31/18   ·   Latest:  ‘10-Q’ on 11/6/23 for 9/30/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/13/17  Vivos Inc                         10-Q        9/30/17   53:2.8M                                   M2 Compliance/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    264K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     24K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     24K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     19K 
11: R1          Document and Entity Information                     HTML     37K 
12: R2          Condensed Balance Sheets                            HTML     89K 
13: R3          Condensed Balance Sheets (Parenthetical)            HTML     35K 
14: R4          Condensed Statements of Operations (Unaudited)      HTML     75K 
15: R5          Condensed Statements of Cash Flow (Unaudited)       HTML    105K 
16: R6          Basis of Presentation and Significant Accounting    HTML     40K 
                Policies                                                         
17: R7          Going Concern                                       HTML     27K 
18: R8          Fixed Assets                                        HTML     26K 
19: R9          Intangible Assets                                   HTML     24K 
20: R10         Related Party Transactions                          HTML     22K 
21: R11         Convertible Notes Payable                           HTML     40K 
22: R12         Common Stock Options, Warrants, and Restricted      HTML     69K 
                Stock Units                                                      
23: R13         Stockholders' Equity                                HTML     23K 
24: R14         Supplemental Cash Flow Information                  HTML     24K 
25: R15         Commitments and Contingencies                       HTML     20K 
26: R16         Subsequent Events                                   HTML     20K 
27: R17         Basis of Presentation and Significant Accounting    HTML     45K 
                Policies (Policies)                                              
28: R18         Basis of Presentation and Significant Accounting    HTML     33K 
                Policies (Tables)                                                
29: R19         Fixed Assets (Tables)                               HTML     25K 
30: R20         Intangible Assets (Tables)                          HTML     24K 
31: R21         Convertible Notes Payable (Tables)                  HTML     36K 
32: R22         Common Stock Options, Warrants, and Restricted      HTML     72K 
                Stock Units (Tables)                                             
33: R23         Basis of Presentation and Significant Accounting    HTML     27K 
                Policies - Schedule of Fair Value of Financial                   
                Instruments (Details)                                            
34: R24         Going Concern (Details Narrative)                   HTML     34K 
35: R25         Fixed Assets (Details Narrative)                    HTML     19K 
36: R26         Fixed Assets - Schedule of Fixed Assets (Details)   HTML     27K 
37: R27         Intangible Assets (Details Narrative)               HTML     20K 
38: R28         Intangible Assets - Schedule of Intangible Assets   HTML     25K 
                (Details)                                                        
39: R29         Related Party Transactions (Details Narrative)      HTML     36K 
40: R30         Convertible Notes Payable (Details Narrative)       HTML     65K 
41: R31         Convertible Notes Payable - Schedule of             HTML     42K 
                Convertible Notes Payable (Details)                              
42: R32         Convertible Notes Payable - Schedule of             HTML     59K 
                Convertible Notes Payable (Details)                              
                (Parenthetical)                                                  
43: R33         Common Stock Options, Warrants and Restricted       HTML     24K 
                Stock Units (Details Narrative)                                  
44: R34         Common Stock Options, Warrants and Restricted       HTML     69K 
                Stock Units - Schedule Summarizes Changes in Stock               
                Option (Details)                                                 
45: R35         Common Stock Options, Warrants and Restricted       HTML     69K 
                Stock Units - Schedule Summarizes Changes in Stock               
                Warrants (Details)                                               
46: R36         Common Stock Options, Warrants and Restricted       HTML     35K 
                Stock Units - Schedule Summarizes Changes in                     
                Restricted Stock Units (Details)                                 
47: R37         Stockholders' Equity (Details Narrative)            HTML     80K 
48: R38         Supplemental Cash Flow Information (Details         HTML     73K 
                Narrative)                                                       
49: R39         Commitments and Contingencies (Details Narrative)   HTML     19K 
50: R40         Subsequent Events (Details Narrative)               HTML     37K 
52: XML         IDEA XML File -- Filing Summary                      XML     92K 
51: EXCEL       IDEA Workbook of Financial Reports                  XLSX     45K 
 5: EX-101.INS  XBRL Instance -- admd-20170930                       XML    729K 
 7: EX-101.CAL  XBRL Calculations -- admd-20170930_cal               XML    126K 
 8: EX-101.DEF  XBRL Definitions -- admd-20170930_def                XML    353K 
 9: EX-101.LAB  XBRL Labels -- admd-20170930_lab                     XML    680K 
10: EX-101.PRE  XBRL Presentations -- admd-20170930_pre              XML    520K 
 6: EX-101.SCH  XBRL Schema -- admd-20170930                         XSD    116K 
53: ZIP         XBRL Zipped Folder -- 0001493152-17-012763-xbrl      Zip     71K 


‘EX-101.CAL’   —   XBRL Calculations — admd-20170930_cal


This Exhibit is an XBRL XML File.


                                                                                                                                                                                
<?xml version="1.0" standalone="no" encoding="windows-1252"?>
<!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.20a -->
<!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
<!-- Field: Doc-Info; Name: Source; Value: ADMD %2D 20170930 10Q Q3 DFN.xfr; Date: 2017%2D11%2D13T10:18:33Z -->
<!-- Field: Doc-Info; Name: Status; Value: 0x8003000A -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://isotopeworld.com/role/DocumentAndEntityInformation" xlink:href="admd-20170930.xsd#DocumentAndEntityInformation" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/BalanceSheets" xlink:href="admd-20170930.xsd#BalanceSheets" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/BalanceSheetsParenthetical" xlink:href="admd-20170930.xsd#BalanceSheetsParenthetical" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/StatementsOfOperations" xlink:href="admd-20170930.xsd#StatementsOfOperations" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/StatementsOfCashFlow" xlink:href="admd-20170930.xsd#StatementsOfCashFlow" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/BasisOfPresentationAndSignificantAccountingPolicies" xlink:href="admd-20170930.xsd#BasisOfPresentationAndSignificantAccountingPolicies" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/GoingConcern" xlink:href="admd-20170930.xsd#GoingConcern" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/FixedAssets" xlink:href="admd-20170930.xsd#FixedAssets" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/IntangibleAssets" xlink:href="admd-20170930.xsd#IntangibleAssets" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/RelatedPartyTransactions" xlink:href="admd-20170930.xsd#RelatedPartyTransactions" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/ConvertibleNotesPayable" xlink:href="admd-20170930.xsd#ConvertibleNotesPayable" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/CommonStockOptionsWarrantsAndRestrictedStockUnits" xlink:href="admd-20170930.xsd#CommonStockOptionsWarrantsAndRestrictedStockUnits" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/StockholdersEquity" xlink:href="admd-20170930.xsd#StockholdersEquity" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/SupplementalCashFlowInformation" xlink:href="admd-20170930.xsd#SupplementalCashFlowInformation" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/CommitmentsAndContingencies" xlink:href="admd-20170930.xsd#CommitmentsAndContingencies" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/SubsequentEvents" xlink:href="admd-20170930.xsd#SubsequentEvents" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies" xlink:href="admd-20170930.xsd#BasisOfPresentationAndSignificantAccountingPoliciesPolicies" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/BasisOfPresentationAndSignificantAccountingPoliciesTables" xlink:href="admd-20170930.xsd#BasisOfPresentationAndSignificantAccountingPoliciesTables" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/FixedAssetsTables" xlink:href="admd-20170930.xsd#FixedAssetsTables" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/IntangibleAssetsTables" xlink:href="admd-20170930.xsd#IntangibleAssetsTables" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/ConvertibleNotesPayableTables" xlink:href="admd-20170930.xsd#ConvertibleNotesPayableTables" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/CommonStockOptionsWarrantsAndRestrictedStockUnitsTables" xlink:href="admd-20170930.xsd#CommonStockOptionsWarrantsAndRestrictedStockUnitsTables" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/BasisOfPresentationAndSignificantAccountingPolicies-ScheduleOfFairValueOfFinancialInstrumentsDetails" xlink:href="admd-20170930.xsd#BasisOfPresentationAndSignificantAccountingPolicies-ScheduleOfFairValueOfFinancialInstrumentsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/GoingConcernDetailsNarrative" xlink:href="admd-20170930.xsd#GoingConcernDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/FixedAssetsDetailsNarrative" xlink:href="admd-20170930.xsd#FixedAssetsDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/FixedAssets-ScheduleOfFixedAssetsDetails" xlink:href="admd-20170930.xsd#FixedAssets-ScheduleOfFixedAssetsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/IntangibleAssetsDetailsNarrative" xlink:href="admd-20170930.xsd#IntangibleAssetsDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/IntangibleAssets-ScheduleOfIntangibleAssetsDetails" xlink:href="admd-20170930.xsd#IntangibleAssets-ScheduleOfIntangibleAssetsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="admd-20170930.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/ConvertibleNotesPayableDetailsNarrative" xlink:href="admd-20170930.xsd#ConvertibleNotesPayableDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/ConvertibleNotesPayable-ScheduleOfConvertibleNotesPayableDetails" xlink:href="admd-20170930.xsd#ConvertibleNotesPayable-ScheduleOfConvertibleNotesPayableDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/ConvertibleNotesPayable-ScheduleOfConvertibleNotesPayableDetailsParenthetical" xlink:href="admd-20170930.xsd#ConvertibleNotesPayable-ScheduleOfConvertibleNotesPayableDetailsParenthetical" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/CommonStockOptionsWarrantsAndRestrictedStockUnitsDetailsNarrative" xlink:href="admd-20170930.xsd#CommonStockOptionsWarrantsAndRestrictedStockUnitsDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/CommonStockOptionsWarrantsAndRestrictedStockUnits-ScheduleSummarizesChangesInStockOptionDetails" xlink:href="admd-20170930.xsd#CommonStockOptionsWarrantsAndRestrictedStockUnits-ScheduleSummarizesChangesInStockOptionDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/CommonStockOptionsWarrantsAndRestrictedStockUnits-ScheduleSummarizesChangesInStockWarrantsDetails" xlink:href="admd-20170930.xsd#CommonStockOptionsWarrantsAndRestrictedStockUnits-ScheduleSummarizesChangesInStockWarrantsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/CommonStockOptionsWarrantsAndRestrictedStockUnits-ScheduleSummarizesChangesInRestrictedStockUnitsDetails" xlink:href="admd-20170930.xsd#CommonStockOptionsWarrantsAndRestrictedStockUnits-ScheduleSummarizesChangesInRestrictedStockUnitsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/StockholdersEquityDetailsNarrative" xlink:href="admd-20170930.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:href="admd-20170930.xsd#SupplementalCashFlowInformationDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="admd-20170930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://isotopeworld.com/role/SubsequentEventsDetailsNarrative" xlink:href="admd-20170930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Balance Sheets">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCash" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaapDepositsAssetsNoncurrent"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssetsNoncurrent" xlink:to="loc_us-gaapDepositsAssetsNoncurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaapInterestPayableCurrent"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapInterestPayableCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaapConvertibleNotesPayableCurrent"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapConvertibleNotesPayableCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesCurrent"/>
<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDerivativeLiabilitiesCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrent"/>
<link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDueToRelatedPartiesCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="loc_us-gaapAccountsPayableRelatedPartiesCurrent"/>
<link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableRelatedPartiesCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapitalPreferredStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalPreferredStock"/>
<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapitalPreferredStock" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Balance Sheets (Parenthetical)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Statements of Operations (Unaudited)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaapStockOptionPlanExpense"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapStockOptionPlanExpense" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="loc_us-gaapLaborAndRelatedExpense"/>
<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapLaborAndRelatedExpense" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense"/>
<link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="admd-20170930.xsd#ADMD_ReservedStockUnitsGranted" xlink:label="loc_ADMDReservedStockUnitsGranted"/>
<link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_ADMDReservedStockUnitsGranted" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FeesAndCommissions" xlink:label="loc_us-gaapFeesAndCommissions"/>
<link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapFeesAndCommissions" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SalesRevenueServicesNet" xlink:label="loc_us-gaapSalesRevenueServicesNet"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapSalesRevenueServicesNet" xlink:type="arc" weight="1"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainsLossesOnSalesOfAssets" xlink:label="loc_us-gaapGainsLossesOnSalesOfAssets"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapGainsLossesOnSalesOfAssets" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="admd-20170930.xsd#ADMD_NetGainLossOnSettlementOfDebt" xlink:label="loc_ADMDNetGainLossOnSettlementOfDebt"/>
<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_ADMDNetGainLossOnSettlementOfDebt" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="admd-20170930.xsd#ADMD_GainLossOnSaleOfStock" xlink:label="loc_ADMDGainLossOnSaleOfStock"/>
<link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_ADMDGainLossOnSaleOfStock" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/StatementsOfCashFlow" xlink:title="00000005 - Statement - Condensed Statements of Cash Flow (Unaudited)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainsLossesOnSalesOfAssets" xlink:label="loc_us-gaapGainsLossesOnSalesOfAssets"/>
<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainsLossesOnSalesOfAssets" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="admd-20170930.xsd#ADMD_PreferredAndCommonStockIssuedForLoanFees" xlink:label="loc_ADMDPreferredAndCommonStockIssuedForLoanFees"/>
<link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ADMDPreferredAndCommonStockIssuedForLoanFees" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices"/>
<link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="admd-20170930.xsd#ADMD_PreferredStockForServices" xlink:label="loc_ADMDPreferredStockForServices"/>
<link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ADMDPreferredStockForServices" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="admd-20170930.xsd#ADMD_PreferredStockForWages" xlink:label="loc_ADMDPreferredStockForWages"/>
<link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ADMDPreferredStockForWages" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaapStockOptionPlanExpense"/>
<link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapStockOptionPlanExpense" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="admd-20170930.xsd#ADMD_StockOptionsAndWarrantsIssuedForServices" xlink:label="loc_ADMDStockOptionsAndWarrantsIssuedForServices"/>
<link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ADMDStockOptionsAndWarrantsIssuedForServices" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet"/>
<link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1" xlink:label="loc_us-gaapDebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1"/>
<link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense"/>
<link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable"/>
<link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableRelatedParties"/>
<link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableRelatedParties" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInEmployeeRelatedLiabilities"/>
<link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="loc_us-gaapIncreaseDecreaseInInterestPayableNet"/>
<link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInterestPayableNet" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="admd-20170930.xsd#ADMD_CommonStockIssuedForWages" xlink:label="loc_ADMDCommonStockIssuedForWages"/>
<link:calculationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ADMDCommonStockIssuedForWages" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
<link:calculationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromContributedCapital" xlink:label="loc_us-gaapProceedsFromContributedCapital"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromContributedCapital" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsOfLoanCosts" xlink:label="loc_us-gaapPaymentsOfLoanCosts"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfLoanCosts" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt" xlink:label="loc_us-gaapRepaymentsOfConvertibleDebt"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfConvertibleDebt" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises"/>
<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromWarrantExercises" xlink:type="arc" weight="1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/BasisOfPresentationAndSignificantAccountingPolicies" xlink:title="00000006 - Disclosure - Basis of Presentation and Significant Accounting Policies"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/GoingConcern" xlink:title="00000007 - Disclosure - Going Concern"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/FixedAssets" xlink:title="00000008 - Disclosure - Fixed Assets"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/IntangibleAssets" xlink:title="00000009 - Disclosure - Intangible Assets"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/RelatedPartyTransactions" xlink:title="00000010 - Disclosure - Related Party Transactions"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/ConvertibleNotesPayable" xlink:title="00000011 - Disclosure - Convertible Notes Payable"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/CommonStockOptionsWarrantsAndRestrictedStockUnits" xlink:title="00000012 - Disclosure - Common Stock Options, Warrants, and Restricted Stock Units"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/StockholdersEquity" xlink:title="00000013 - Disclosure - Stockholders' Equity"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/SupplementalCashFlowInformation" xlink:title="00000014 - Disclosure - Supplemental Cash Flow Information"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/CommitmentsAndContingencies" xlink:title="00000015 - Disclosure - Commitments and Contingencies"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/SubsequentEvents" xlink:title="00000016 - Disclosure - Subsequent Events"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies" xlink:title="00000017 - Disclosure - Basis of Presentation and Significant Accounting Policies (Policies)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/BasisOfPresentationAndSignificantAccountingPoliciesTables" xlink:title="00000018 - Disclosure - Basis of Presentation and Significant Accounting Policies (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/FixedAssetsTables" xlink:title="00000019 - Disclosure - Fixed Assets (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/IntangibleAssetsTables" xlink:title="00000020 - Disclosure - Intangible Assets (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/ConvertibleNotesPayableTables" xlink:title="00000021 - Disclosure - Convertible Notes Payable (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/CommonStockOptionsWarrantsAndRestrictedStockUnitsTables" xlink:title="00000022 - Disclosure - Common Stock Options, Warrants, and Restricted Stock Units (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/BasisOfPresentationAndSignificantAccountingPolicies-ScheduleOfFairValueOfFinancialInstrumentsDetails" xlink:title="00000023 - Disclosure - Basis of Presentation and Significant Accounting Policies - Schedule of Fair Value of Financial Instruments (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/GoingConcernDetailsNarrative" xlink:title="00000024 - Disclosure - Going Concern (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/FixedAssetsDetailsNarrative" xlink:title="00000025 - Disclosure - Fixed Assets (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/FixedAssets-ScheduleOfFixedAssetsDetails" xlink:title="00000026 - Disclosure - Fixed Assets - Schedule of Fixed Assets (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/IntangibleAssetsDetailsNarrative" xlink:title="00000027 - Disclosure - Intangible Assets (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/IntangibleAssets-ScheduleOfIntangibleAssetsDetails" xlink:title="00000028 - Disclosure - Intangible Assets - Schedule of Intangible Assets (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000029 - Disclosure - Related Party Transactions (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/ConvertibleNotesPayableDetailsNarrative" xlink:title="00000030 - Disclosure - Convertible Notes Payable (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/ConvertibleNotesPayable-ScheduleOfConvertibleNotesPayableDetails" xlink:title="00000031 - Disclosure - Convertible Notes Payable - Schedule of Convertible Notes Payable (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/ConvertibleNotesPayable-ScheduleOfConvertibleNotesPayableDetailsParenthetical" xlink:title="00000032 - Disclosure - Convertible Notes Payable - Schedule of Convertible Notes Payable (Details) (Parenthetical)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/CommonStockOptionsWarrantsAndRestrictedStockUnitsDetailsNarrative" xlink:title="00000033 - Disclosure - Common Stock Options, Warrants and Restricted Stock Units (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/CommonStockOptionsWarrantsAndRestrictedStockUnits-ScheduleSummarizesChangesInStockOptionDetails" xlink:title="00000034 - Disclosure - Common Stock Options, Warrants and Restricted Stock Units - Schedule Summarizes Changes in Stock Option (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/CommonStockOptionsWarrantsAndRestrictedStockUnits-ScheduleSummarizesChangesInStockWarrantsDetails" xlink:title="00000035 - Disclosure - Common Stock Options, Warrants and Restricted Stock Units - Schedule Summarizes Changes in Stock Warrants (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/CommonStockOptionsWarrantsAndRestrictedStockUnits-ScheduleSummarizesChangesInRestrictedStockUnitsDetails" xlink:title="00000036 - Disclosure - Common Stock Options, Warrants and Restricted Stock Units - Schedule Summarizes Changes in Restricted Stock Units (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000037 - Disclosure - Stockholders' Equity (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:title="00000038 - Disclosure - Supplemental Cash Flow Information (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000039 - Disclosure - Commitments and Contingencies (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://isotopeworld.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000040 - Disclosure - Subsequent Events (Details Narrative)"/>
</link:linkbase>

Top
Filing Submission 0001493152-17-012763   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 12:03:53.1pm ET